Armata Pharmaceuticals (ARMP) Preferred Shares (2013 - 2014)

Armata Pharmaceuticals (ARMP) posted Preferred Shares of $87000.0 for Q3 2014, little changed sequentially from $87000.0 in Q2 2014.

Armata Pharmaceuticals (ARMP) Preferred Shares (2013 - 2014) Analysis & Trends

Armata Pharmaceuticals has reported Preferred Shares for 2 years, with the latest figure at $87000.0 in Q3 2014.

Quarterly Preferred Shares changed N/A year-over-year to $87000.0 in Q3 2014, while the trailing twelve-month figure through Sep 2014 was $87000.0 (changed N/A YoY) and the FY2013 annual result came in at $89000.0, changed N/A from the prior year.
Preferred Shares steadied at $87000.0 in Q3 2014 per ARMP's latest filing, from $87000.0 in the prior quarter.
Over five years, Preferred Shares peaked at $89000.0 in Q4 2013 and troughed at $87000.0 in Q2 2014.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares (Qtr)
1	Vertex Pharmaceuticals	139.13 Bn	131.28 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	85.77 Bn	77.77 Bn	3.93 Bn	-
3	Argenx Se	64.64 Bn	59.46 Bn	1.37 Bn	-
4	Moderna	58.29 Bn	53.16 Bn	52.00 Mn	-
5	BeOne Medicines	41.92 Bn	36.82 Bn	1.53 Bn	-
6	Alnylam Pharmaceuticals	31.58 Bn	28.28 Bn	992.69 Mn	-
7	BioNTech SE	28.12 Bn	9.73 Bn	668.28 Mn	-
8	Insmed	27.39 Bn	26.22 Bn	358.27 Mn	-
9	Royalty Pharma	27.27 Bn	26.43 Bn	-	-
10	Armata Pharmaceuticals	182.82 Mn	158.82 Mn	-	-

Download Data